| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |